Kennedy said the Department of Health and Human Services would retire all 17 current members of the ACIP, citing what he ...

Comparative assessments and other editorial opinions are those of U.S. News and have not been previously reviewed, approved ...

After nearly 25 years with Sanofi, Sanjay Gurunathan, M.D., has left for GSK, where he will lead vaccine and infectious ...

The benefits of 52-week biologic therapy on asthma control and lung function are observed in both never smokers and ...

The release of Pretty Hurts comes two years after GSK collaborated with Lifetime on a short film highlighting the risks associated with meningitis B.

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

Sublime’s award is just one of the 24 that were rolled back after U.S. Secretary of Energy Chris Wright announced the awards ...

The BioWorld Biopharmaceutical Index extended its downward trend over April and May, closing the latter month down 6.47% after reaching a peak gain of 9.64% at the end of February. The Nasdaq ...

GSK PLC GSK shares rallied 1.20% to £15.12 Thursday, on what proved to be an all-around favorable trading session for the ...

Research conducted at Uskudar University (Istanbul, Turkey) explored the neuroprotective potential of ethanolic extracts of ...

In addition, mirvetuximab soravtansine (Elahere) was the first targeted therapy to demonstrate an improvement in OS in ...

GSK PLC closed 11.54% below its 52-week high of £16.79, which the company reached on September 9th.